Litcius/Paper detail

Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study

Habib El-Khoury, David J Lee, Jean-Baptiste Alberge, Robert Redd, Christian J Cea-Curry, Jacqueline Perry, Hadley Barr, Ciara Murphy, Dhananjay Sakrikar, David Barnidge, Mark Bustoros, Houry Leblebjian, Anna Cowan, Maya I Davis, Julia Amstutz, Cody J Boehner, Elizabeth D Lightbody, Romanos Sklavenitis-Pistofidis, Mark C Perkins, Stephen Harding, Clifton C Mo, Prashant Kapoor, Joseph Mikhael, Ivan M Borrello, Rafael Fonseca, Scott T Weiss, Elizabeth Karlson, Lorenzo Trippa, Timothy R Rebbeck, Gad Getz, Catherine R Marinac, Irene M Ghobrial

2022The Lancet Haematology78 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMultiple myelomaInternal medicinePopulationCohort studyPopulation based studyOncologyCohortMonoclonal gammopathy of undetermined significanceEpidemiologyMonoclonalMEDLINECancerRetrospective cohort studyHematologic NeoplasmsPediatricsPopulation studyProportional hazards modelComorbidityYoung adultMulticenter studyImmunologySurrogate endpointClinical trialImmunopathologyMultiple Myeloma Research and TreatmentsAmyloidosis: Diagnosis, Treatment, OutcomesCancer and biochemical research